New York Man Sentenced To 56 Months In Prison For Defrauding Investors Of More Than $3.5 Million Through Securities Offering Scheme
U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma
NEW YORK COMMUNITY BANCORP, INC. TO REPORT FIRST QUARTER 2022 EARNINGS AND HOST CONFERENCE CALL ON APRIL 27TH
John Theurer Cancer Center Treats First Patient in U.S. with Investigational New Treatment for Brain Cancer
Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference
